| abstract |
Since the peptide according to the present invention has a simple structure as compared with the conventional natural human erythropoietin, it can be easily passed through the tissue-blood barrier, has excellent physiological activity in protecting the cell, The pharmaceutical composition containing the erythropoietin-derived peptide of the present invention as an active ingredient has economic advantages and no side effects of cell proliferation. The pharmaceutical composition containing the erythropoietin-derived peptide of the present invention is useful as a pharmaceutical composition for treating diseases of cell injury such as stroke, mechanical damage or ischemic injury, myocardial infarction, , And a pharmaceutical composition for preventing cell damage. |